A phase II trial of Capecitabine (X) and Irinotecan (I) in a biweekly schedule in patients with untreated advanced colorectal cancer (ACRC)

被引：0
|
作者：
Garcia-Alfonso, P.
Perez MAnga, G.
Gonzalez, M. C.
Lopez, P.
Gonzalez, E.
Belon, J.
Molina, M.
Pachon, V.
Iglesias, L.
Siso, I.
机构：
[1] Hosp Univ Gregorio Maranon, Med Oncol Serv, Madrid, Spain
[2] Hosp Mostoles, Med Oncol Serv, Madrid, Spain
[3] Hosp Univ Virgen Nieves, Med Oncol Serv, Granada, Spain
[4] Hosp Gen Segovia, Med Oncol Serv, Segovia, Spain
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [41] Phase I–II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclines
    Patrizia Vici
    Alessandra Fabi
    Giulio Metro
    Domenico Sergi
    Diana Giannarelli
    Luigi Di Lauro
    Gerold Bepler
    Federica Tomao
    Francesco Cognetti
    Francesca Conti
    Massimo Lopez
    [J]. Cancer Chemotherapy and Pharmacology, 2011, 67 : 687 - 693
  • [42] Phase I study of the HDAC inhibitor vorinostat in combination with capecitabine in a biweekly schedule in advanced breast cancer.
    James, Edward Samuel
    Chung, Gina
    Sowers, Noelle Marie
    Clark, Mary Beth
    Lilian, Rebecca
    Abraham, Gineesha
    Chmael, Susan
    Cappiello, Michelle
    DiGiovanna, Michael
    Hofstatter, Erin Wysong
    Sanft, Tara Beth
    Israel, Gary M.
    Pusztai, Lajos
    Harris, Lyndsay
    Abu-Khalaf, Maysa M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [43] Pharmacokinetics of Irinotecan in Combination with Biweekly Cetuximab in Patients with Advanced Colorectal Cancer
    Czejka, Martin
    Gruenberger, Birgit
    Kiss, Andreas
    Farkouh, Andre
    Schueller, Johannes
    [J]. ANTICANCER RESEARCH, 2010, 30 (06) : 2355 - 2360
  • [44] Phase II study of weekly irinotecan (CPT-11) associated to protracted oral tegafur (TGF) in previously untreated, advanced colorectal cancer (ACRC)
    Saigi, E
    Batiste-Alentorn, E
    Diaz, N
    Galan, A
    Salud, A
    Campos, JM
    Losa, F
    Gallen, M
    Massuti, B
    Asensio, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 302S - 302S
  • [45] Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study
    Rosati, G.
    Cordio, S.
    Bordonaro, R.
    Caputo, G.
    Novello, G.
    Reggiardo, G.
    Manzione, L.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (04) : 781 - 786
  • [46] Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomised phase II study
    Price, T. J.
    Townsend, A. R.
    Khattak, A.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (10) : 2121 - 2121
  • [47] A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer
    S C Oh
    H Y Sur
    H J Sung
    I K Choi
    S S Park
    J H Seo
    Y T Jeen
    H J Chun
    S W Shin
    Y J Mok
    J S Kim
    Y H Kim
    [J]. British Journal of Cancer, 2007, 96 : 1514 - 1519
  • [48] A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer
    Oh, S. C.
    Sur, H. Y.
    Sung, H. J.
    Choi, I. K.
    Park, S. S.
    Seo, J. H.
    Jeen, Y. T.
    Chun, H. J.
    Shin, S. W.
    Mok, Y. J.
    Kim, J. S.
    Kim, Y. H.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 96 (10) : 1514 - 1519
  • [49] Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients
    Moehler, Markus
    Sprinzl, Martin F.
    Abdelfattah, Murad
    Schimanski, Carl C.
    Adami, Bernd
    Godderz, Werner
    Majer, Klaus
    Flieger, Dimitri
    Teufel, Andreas
    Siebler, Juergen
    Hoehler, Thomas
    Galle, Peter R.
    Kanzler, Stephan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (04) : 449 - 456
  • [50] Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients
    Markus Moehler
    Martin F Sprinzl
    Murad Abdelfattah
    Carl C Schimanski
    Bernd Adami
    Werner Godderz
    Klaus Majer
    Dimitri Flieger
    Andreas Teufel
    Juergen Siebler
    Thomas Hoehler
    Peter R Galle
    Stephan Kanzler
    [J]. World Journal of Gastroenterology, 2009, 15 (04) : 449 - 456
12345